{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:40:56Z","timestamp":1767980456607,"version":"3.49.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>We explored the mechanisms and molecular targets of Ejiao Siwu Decoction (EJSW) for treating primary immune thrombocytopenia (ITP) using network pharmacology and molecular docking. Active compounds of EJSW were identified by high-performance liquid chromatography-diode array detector (HPLC-DAD) and high-performance liquid chromatography-mass spectrometry (HPLC-MS) and their targets were obtained from HERB and SwissTargetPrediction, and ITP targets were obtained from Comparative Toxicogenomics Database (CTD) and GeneCards. STRING and Cytoscape were used for protein-protein interaction (PPI) network analysis. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses by WebGestalt yielded a gene-pathway network, Autodock molecular docking was applied to screen targets and active compounds, and cytokines were detected using a cytometric bead array (CBA) human inflammation kit. We identified 14 compounds and 129 targets, and 1,726 ITP targets. RAC-alpha serine\/threonine-protein kinase (AKT1), tumour necrosis factor (TNF), interleukin-6 (IL6), caspase-3 (CASP3) and tumour suppressor protein (TP53) were core targets (nodes and edges). Functional annotation identified cofactor binding and coenzyme binding, and 20 significantly enriched pathways. Active compounds of EJSW were successfully docked with ITP targets. Tumour necrosis factor alpha (TNF-\u03b1) and interleukin-1 beta (IL-1\u03b2) were upregulated in ITP patients, vascular endothelial growth factor A (VEGF-A) and vascular endothelial growth factor D (VEGF-D) were downregulated, and EJSW treatment reversed these trends. EJSW may regulate key ITP targets based on the <jats:italic>in silico<\/jats:italic> analyses, and protect vascular integrity through AGE-RAGE signalling, complement and coagulation cascades, and VEGF signalling by downregulating TNF-\u03b1, IL-1\u03b2 and other inflammatory factors.<\/jats:p>","DOI":"10.3389\/fmed.2022.891230","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T08:22:30Z","timestamp":1657700550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Mechanism and Molecular Targets of Ejiao Siwu Decoction for Treating Primary Immune Thrombocytopenia Based on High-Performance Liquid Chromatograph, Network Pharmacology, Molecular Docking and Cytokines Validation"],"prefix":"10.3389","volume":"9","author":[{"given":"Ming Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Ning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Qing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Min","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Mei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.lpm.2014.02.004","article-title":"ITP and international guidelines: what do we know, what do we need?","volume":"43","author":"Rodeghiero","year":"2014","journal-title":"Presse Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1172\/jci113060","article-title":"Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance.","volume":"80","author":"Ballem","year":"1987","journal-title":"J Clin Invest."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.2147\/dddt.S299591","article-title":"Review of romiplostim mechanism of action and clinical applicability.","volume":"15","author":"Bussel","year":"2021","journal-title":"Drug Des Devel Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1182\/blood-2002-05-1475","article-title":"Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro.","volume":"102","author":"Chang","year":"2003","journal-title":"Blood."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1182\/blood-2003-08-2672","article-title":"Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP.","volume":"103","author":"McMillan","year":"2004","journal-title":"Blood."},{"key":"B6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1749-6632.1965.tb18984.x","article-title":"Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies.","volume":"124","author":"Shulman","year":"1965","journal-title":"Ann N Y Acad Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00277-016-2703-1","article-title":"Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis.","volume":"95","author":"Khodadi","year":"2016","journal-title":"Ann Hematol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.thromres.2016.10.028","article-title":"Granulocyte colony-stimulating factor decreases the Th1\/Th2 ratio in peripheral blood mononuclear cells from patients with chronic immune thrombocytopenic purpura in vitro.","volume":"148","author":"Ge","year":"2016","journal-title":"Thromb Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.intimp.2019.04.061","article-title":"The potential therapeutic benefit of resveratrol on Th17\/Treg imbalance in immune thrombocytopenic purpura.","volume":"73","author":"Guo","year":"2019","journal-title":"Int Immunopharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"911","DOI":"10.19746\/j.cnki.issn.1009-2137.2019.03.044","article-title":"[Expression of CD19(+)B cells and involvement of serum breg in pathogenesis of immune thrombocytopenia].","volume":"27","author":"Di","year":"2019","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6020016","article-title":"Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP).","volume":"6","author":"Zufferey","year":"2017","journal-title":"J Clin Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1182\/blood-2017-03-754119","article-title":"Clinical updates in adult immune thrombocytopenia.","volume":"129","author":"Lambert","year":"2017","journal-title":"Blood."},{"key":"B13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ctim.2013.08.005","article-title":"Alternative therapy for persistent childhood immune thrombocytopenic purpura unresponsive to intravenous immunoglobulin.","volume":"21","author":"Huang","year":"2013","journal-title":"Complement Ther Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11655-007-0033-9","article-title":"Treatment of 37 patients with refractory idiopathic thrombocytopenic purpura by Shengxueling.","volume":"13","author":"Shao","year":"2007","journal-title":"Chin J Integr Med."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00597","article-title":"Integrated network pharmacology and metabolomics analysis of the therapeutic effects of Zi Dian Fang on immune thrombocytopenic purpura.","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/s0254-6272(16)30066-8","article-title":"Effects and mechanisms of Bazhen decoction, Siwu decoction, and Sijunzi decoction on 5-fluorouracil-induced anemia in mice.","volume":"36","author":"Tian","year":"2016","journal-title":"J Tradit Chin Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.5582\/ddt.2014.01038","article-title":"Chemical constituents and bioactivities of Colla corii asini.","volume":"8","author":"Wang","year":"2014","journal-title":"Drug Discov Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery.","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat Chem Biol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2960372","article-title":"Network pharmacology approach to explore the pharmacological mechanism of xiaoyao powder on anovulatory infertility.","volume":"2016","author":"Liu","year":"2016","journal-title":"Evid Based Complement Alternat Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jpba.2017.04.012","article-title":"Systematically characterize the absorbed effective substances of Wutou decoction and their metabolic pathways in rat plasma using UHPLC-Q-TOF-MS combined with a target network pharmacological analysis.","volume":"141","author":"Xu","year":"2017","journal-title":"J Pharm Biomed Anal."},{"key":"B21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/s1875-5364(13)60037-0","article-title":"Traditional Chinese medicine network pharmacology: theory, methodology and application.","volume":"11","author":"Li","year":"2013","journal-title":"Chin J Nat Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.3892\/etm.2017.5170","article-title":"A network pharmacology approach to investigate the pharmacological effects of Guizhi Fuling Wan on uterine fibroids.","volume":"14","author":"Zeng","year":"2017","journal-title":"Exp Ther Med."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bax028","article-title":"GeneHancer: genome-wide integration of enhancers and target genes in genecards.","volume":"2017","author":"Fishilevich","year":"2017","journal-title":"Database (Oxford)."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083922","article-title":"Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology.","volume":"8","author":"Hsin","year":"2013","journal-title":"PLoS One."},{"key":"B25","doi-asserted-by":"publisher","first-page":"W507","DOI":"10.1093\/nar\/gkw335","article-title":"systemsDock: a web server for network pharmacology-based prediction and analysis.","volume":"44","author":"Hsin","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible.","volume":"45","author":"Szklarczyk","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs.","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.rmed.2019.03.017","article-title":"Th2\/Th17 cytokine profile in phenotyped Greek asthmatics and relationship to biomarkers of inflammation.","volume":"151","author":"Domvri","year":"2019","journal-title":"Respir Med."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/147648","article-title":"Protein-protein interaction detection: methods and analysis.","volume":"2014","author":"Rao","year":"2014","journal-title":"Int J Proteomics."},{"key":"B31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/npp.2015.215","article-title":"Genetic approaches to hypothalamic-pituitary-adrenal axis regulation.","volume":"41","author":"Arnett","year":"2016","journal-title":"Neuropsychopharmacology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.psyneuen.2012.05.006","article-title":"The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.","volume":"38","author":"Lembke","year":"2013","journal-title":"Psychoneuroendocrinology."},{"key":"B33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11684-014-0349-8","article-title":"Clinical phenotype network: the underlying mechanism for personalized diagnosis and treatment of traditional Chinese medicine.","volume":"8","author":"Zhou","year":"2014","journal-title":"Front Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1161\/01.Cir.0000151307.10576.02","article-title":"Gallic acid antagonizes P-selectin-mediated platelet-leukocyte interactions: implications for the French paradox.","volume":"111","author":"Appeldoorn","year":"2005","journal-title":"Circulation."},{"key":"B35","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.freeradbiomed.2019.08.019","article-title":"p38 MAP-kinase inhibitor protects against platelet-activating factor-induced death in mice.","volume":"143","author":"Abhilasha","year":"2019","journal-title":"Free Radic Biol Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.biopha.2018.07.161","article-title":"Caffeic acid protects against IL-1\u03b2-induced inflammatory responses and cartilage degradation in articular chondrocytes.","volume":"107","author":"Huang","year":"2018","journal-title":"Biomed Pharmacother."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2022.113327","article-title":"Verbascoside protects from LPS-induced septic cardiomyopathy via alleviating cardiac inflammation, oxidative stress and regulating mitochondrial dynamics.","volume":"233","author":"Zhu","year":"2022","journal-title":"Ecotoxicol Environ Saf."},{"key":"B38","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s11064-020-03206-9","article-title":"Verbascoside attenuates acute inflammatory injury caused by an intracerebral hemorrhage through the suppression of NLRP3.","volume":"46","author":"Zhou","year":"2021","journal-title":"Neurochem Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1182\/blood-2010-12-323204","article-title":"An important role for Akt3 in platelet activation and thrombosis.","volume":"118","author":"O\u2019Brien","year":"2011","journal-title":"Blood."},{"key":"B40","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nm.3085","article-title":"Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-\u03b1 in rheumatoid arthritis.","volume":"19","author":"Nie","year":"2013","journal-title":"Nat Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance.","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur J Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/10715762.2019.1694675","article-title":"Hypochlorous acid reversibly inhibits caspase-3: a potential regulator of apoptosis.","volume":"54","author":"Jeelani","year":"2020","journal-title":"Free Radic Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1182\/blood-2003-01-0275","article-title":"Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura.","volume":"103","author":"Houwerzijl","year":"2004","journal-title":"Blood."},{"key":"B44","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1365-2141.2011.08973.x","article-title":"Platelet apoptosis in paediatric immune thrombocytopenia is ameliorated by intravenous immunoglobulin.","volume":"156","author":"Winkler","year":"2012","journal-title":"Br J Haematol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1038\/onc.2016.461","article-title":"Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53.","volume":"36","author":"Swidnicka-Siergiejko","year":"2017","journal-title":"Oncogene."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/1824-7288-40-10","article-title":"Autoimmune haematological disorders in two Italian children with Kabuki syndrome.","volume":"40","author":"Giordano","year":"2014","journal-title":"Ital J Pediatr."},{"key":"B47","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3109\/09537104.2011.633646","article-title":"CD72 gene expression in immune thrombocytopenia.","volume":"23","author":"Zhou","year":"2012","journal-title":"Platelets."},{"key":"B48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/mbc.0000000000000423","article-title":"Interleukin-17-producing CD4+ T lymphocytes are increased in patients with primary immune thrombocytopenia.","volume":"27","author":"Zhou","year":"2016","journal-title":"Blood Coagul Fibrinolysis."},{"key":"B49","first-page":"4385","article-title":"Serum uric acid and inflammation in patients with immune thrombocytopenic purpura: preliminary results.","volume":"19","author":"Dal","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000486811","article-title":"Differential expression of MiR-106b-5p and MiR-200c-3p in newly diagnosed versus chronic primary immune thrombocytopenia patients based on systematic analysis.","volume":"45","author":"Qian","year":"2018","journal-title":"Cell Physiol Biochem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.3892\/mmr.2017.6901","article-title":"MicroRNA profiling of platelets from immune thrombocytopenia and target gene prediction.","volume":"16","author":"Deng","year":"2017","journal-title":"Mol Med Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1160\/th-16-06-0481","article-title":"Plasma microRNAs characterising patients with immune thrombocytopenic purpura.","volume":"117","author":"Zuo","year":"2017","journal-title":"Thromb Haemost."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.imbio.2016.06.005","article-title":"Complement-coagulation crosstalk on cellular and artificial surfaces.","volume":"221","author":"Wiegner","year":"2016","journal-title":"Immunobiology."},{"key":"B54","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1111\/jth.12950","article-title":"Reincarnation of ancient links between coagulation and complement.","author":"Conway","year":"2015","journal-title":"J Thromb Haemost."},{"key":"B55","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/bjh.15062","article-title":"Haemostasis and innate immunity - a complementary relationship: a review of the intricate relationship between coagulation and complement pathways.","volume":"180","author":"Keragala","year":"2018","journal-title":"Br J Haematol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123386","article-title":"Platelet activation mechanisms and consequences of immune thrombocytopenia.","volume":"10","author":"Sun","year":"2021","journal-title":"Cells."},{"key":"B57","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1600-0609.2011.01718.x","article-title":"Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).","volume":"88","author":"Najaoui","year":"2012","journal-title":"Eur J Haematol."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10051004","article-title":"Emerging therapies in immune thrombocytopenia.","volume":"10","author":"Audia","year":"2021","journal-title":"J Clin Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/cei.13475","article-title":"Complement activation in patients with immune thrombocytopenic purpura according to phases of disease course.","volume":"201","author":"Castelli","year":"2020","journal-title":"Clin Exp Immunol."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1182\/blood.202101286","article-title":"Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond.","author":"Gavriilaki","year":"2021","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/bjh.17872","article-title":"Novel therapies for immune thrombocytopenia.","volume":"196","author":"Kuter","year":"2022","journal-title":"Br J Haematol."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9823141","article-title":"Aqueous extract of glucoraphanin-rich broccoli sprouts inhibits formation of advanced glycation end products and attenuates inflammatory reactions in endothelial cells.","volume":"2018","author":"Sotokawauchi","year":"2018","journal-title":"Evid Based Complement Alternat Med."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-014-0162-3","article-title":"Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE.","volume":"14","author":"Matsui","year":"2015","journal-title":"Cardiovasc Diabetol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1182\/blood.2019000200","article-title":"TNF-\u03b1-driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging.","volume":"134","author":"Davizon-Castillo","year":"2019","journal-title":"Blood."},{"key":"B65","doi-asserted-by":"publisher","first-page":"S294","DOI":"10.1097\/00003246-200205001-00020","article-title":"The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis.","volume":"30","author":"Zimmerman","year":"2002","journal-title":"Crit Care Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.molimm.2010.05.009","article-title":"Complement activation on platelets: implications for vascular inflammation and thrombosis.","volume":"47","author":"Peerschke","year":"2010","journal-title":"Mol Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s00277-018-3367-9","article-title":"Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation.","volume":"97","author":"Qu","year":"2018","journal-title":"Ann Hematol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1160\/th13-02-0102","article-title":"Crosstalk between platelets and the complement system in immune protection and disease.","volume":"110","author":"Verschoor","year":"2013","journal-title":"Thromb Haemost."},{"key":"B69","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.thromres.2011.09.026","article-title":"Platelet dysfunction in vascular pathologies and how can it be treated.","volume":"129","author":"Alexandru","year":"2012","journal-title":"Thromb Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.smim.2018.01.003","article-title":"Complement links platelets to innate immunity.","volume":"37","author":"Nording","year":"2018","journal-title":"Semin Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1517\/14728222.2011.641951","article-title":"Targeting the VEGF signaling pathway in cancer therapy.","volume":"16","author":"Waldner","year":"2012","journal-title":"Expert Opin Ther Targets."},{"key":"B72","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/MOH.0b013e32833865e6","article-title":"Multifaceted role of vascular endothelial growth factor signaling in adult tissue physiology: an emerging concept with clinical implications.","volume":"17","author":"Sung","year":"2010","journal-title":"Curr Opin Hematol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/biof.46","article-title":"The function of vascular endothelial growth factor.","volume":"35","author":"Nieves","year":"2009","journal-title":"Biofactors."},{"key":"B74","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1042\/cs20040370","article-title":"The vascular endothelial growth factor (VEGF)\/VEGF receptor system and its role under physiological and pathological conditions.","volume":"109","author":"Takahashi","year":"2005","journal-title":"Clin Sci (Lond)."},{"key":"B75","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1089\/gtmb.2016.0163","article-title":"Association between TNF-\u03b1 -308G\/A polymorphism and risk of immune thrombocytopenia: a meta-analysis.","volume":"21","author":"Zhang","year":"2017","journal-title":"Genet Test Mol Biomarkers."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.891230\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T08:22:36Z","timestamp":1657700556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.891230\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":75,"alternative-id":["10.3389\/fmed.2022.891230"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.891230","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"article-number":"891230"}}